CymaBay Therapeutics 4Q Loss/Shr 35c >CBAY
Please disregard the headline "Gilead Sciences Proposed to Acquire CymaBay for $32.50 Per Shr in Cash or a Total Equity Value of $4.3B," at 4:46 p.m. ET. The...
Source: marketwatch.com
Sciences Proposed News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sciences Proposed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sciences Proposed Today - Breaking & Trending Today